emilpharma 
Dealstreet

ELP acts on Somerset Indus Capital Partners' investment in Emil Pharmaceutical

The deal amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Emil Pharmaceutical Industries Pvt Ltd, a pharmaceutical contract development and manufacturing organization. This marks the fund’s fifth overall and second pharmaceutical investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this deal.

The transaction team consisted of Vinay Butani (Partner), Taskeen Hamid (Counsel) and Vinit Shah (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi High Court Justice Girish Kathpalia recuses from case he dealt with as District Judge

Mindspright Legal acts on Nilachal Carbo Metalicks IPO

Legacy Law Offices advises on Rachit Prints IPO

Unauthorised fundraising for idol installation at Sabarimala: Kerala HC orders completion of probe in 4 months

Multiplexes, producers move Karnataka High Court against ₹200 cap on film ticket prices

SCROLL FOR NEXT